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LETTERS TO THE EDITOR
with cholesterol for 2 weeks, but the effects of such priming were
not addressed', No e .planation was gifen for the large difference in
the concentration of holesterol observed among the three groups
before they were er.posed to ETS (Table 2, column 1). To experi-
mentally investigate the alleged link between ETS and coronary
heart disease, it is essential to use animals free from any other
widely recognized and accepted risk factors of coronary heart
disease, Failure to control for such con€ounders would render any
laboratory findings extremely difficult, if not impossible, to inter-
pret . Zhu et al. could have used animals fed a regular diet as a
control for more properly assessing the possible effects of ETS .
The number of animals used in the control and the "low" and
"high" exposure groups differs by a factor of 2 . Moreover, mete
animals were used. Because the majority of the epidemiologic
studies addressing the possible effects of ETS exposure on coronary
heart disease actually refer to women reportedly exposed to ETS
generated by smoking husbands (3,4), and because important
gender-specific differences have been observed with respect to the
age of onset, clinical manifestation and prognosis of heart disease
(5), it is questionable whether the findings of Zhu et al . can be
readily applied to humans .
Several assays used by Zhu et al . also warrent comment . For
example, methods used to quantify platelet aggregation are known
to be highly sensitive, variable and open to numerous subtleties (6) .
A better marker for platelet abnormality or dysfunction would have
been to measure the level of plasma platelet-derived growth factor
which, because of its generally recognized role in the development
of atherosclerosis (7), could have provided greater insight into
whether ETS exposure deserves to be considered as a factor for
atherosclerosis,
In the absence of other supporting evidence, it is not appropriate
to interpret the measured lipid streaks as equivalent to the develop-
ment of atherosclerosis . Indeed, such streaks have been found in
children as young as 3 years from many countries (regardless of
community prevalence of adult coronary artery disease) (8 .9) .
Given the multitude of factors reportedly associated with athero-
sclerosis, the complex nature and the long incubation period for the
disease to be fully developed, I found the claim of Zhu et al . to be
quite surprising because the three purported major risk factors,
elevated blood pressure, high serum cholesterol concentration,
history of active smoking-collectively are unable to predict >50%
of new cases of the disease (10).
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Reply
We compliment Wu for voluntarily disclosing his financial relation-
ship with the tobacco industry . It is common for tobacco industry
consultants to write letters to the editor criticizing papers implicat-
ing smoking and passive smoking as causes of disease (I), but they
rarely disclose their financial ties .
The issues Wu raises reveal a lack of understanding of the rabbit
model of atherosclerosis we used to demonstrate that exposure to
environmental tobacco smoke (ETS) increases atherosclerosis, as
well as principles of testing environmental toxins generally .
This rabbit model of experimental atheroselerosis has been well
established since 1908 (2). We have used cholesterol-fed rabbits to
make experimental aortic atherosclerosis for several studies (3--7) of
the effects of calcium channel blockers and fish oil on atherosclero-
sis . Consistent with standard practice, the rabbits were primed with
the cholesterol diet for 2 weeks before study to exclude those with
a low response . Rabbits on a zero-cholesterol diet, as Wu suggests,
take years to develop atherosclerosis, and so are not an efficient
experimental mGd l .
We used ma's rabbits for consistency . Epidemiologic studies
show similar clevarions in risk of death from heart disease due to
ETS exposure in men and women (8) . so gender does not appear to
be an important variable .
Wu is correct in stating that the total cholesterol was higher in
the
e:-iio
.l the n in the FTC-exposed rabbits . This difference,
however, would be expected to bias the results against finding an
effect of ETS on lipid deposits in the arteries . Thus, if anything, this
result strengthens our conclusions that ETS increases experimental
atherosclerosis .
In criticizing our experimental design, Wu ignores the fact that
we had control groups that breathed clean air while eating the high
cholesterol diet for the same period of time as the ETS-exposed
rabbits. Exposure to ETS increased lipid deposits over the control
level in a dose-dependent manner .
The methods we used to measure platelet aggregation and
bleeding time for rabbits are well established . For example, we (9)
used these methods to demonstrate that aspirin-a known inhibitor
of platelet function-markedly prolongs bleeding time and reduces
platelet aggregation in cholesterol-fed rabbits . These results are in
general agreement with results of clinical studies (8) of the effects of
ETS on platelet function .
The Sudan IV stain is a well established method for measuring
lipid deposits in experimental atherosclerosis . Rabbits with a zero-
cholesterol diet do not show any gross or histologic evidence of
atherosclerosis, but all aortas from the cholesterol-fed rabbits
had atherosclerotic lesions (9-11) . The lipid lesions of the aorta in
the control rabbits with a cholesterol diet in our study were
consistent with the atherosclerotic model of rabbits in our previous
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stucacs. Sudan IV stain was diffusely present throughout most
aortas in either a patchy distribution or homogeneously over
most of Ili,e surface, and the histologic sections of these lipid lesions
contain more foam cells, smooth muscle cells, macroi :hages and
lipids (12). Undoubtedly, the area of Sudan IV-positive intimal
lesions (cholesterol-induced) in the aorta is associated with some
degree of naturally occurring endothelial injury (3), one of the
parameters of atherosclerosis (14,15) . Although all rabbits in out
study showed lipid deposits, Vie ETS-exposed rabbits showed
significantly
more deposits than did ahe control rabbit :, brew. zing
clear air . l u addition, the lipid streaks that Wu notes are found in
human children are precursors of the development of atherosclero-
sis in adult life (15) .
The rabbits in nur high dose chamber were exposed to smoke
from a smoking machine in the exposure chamber; therefore, they
were exposed to a mixture of fresh tuid aged sidestrearri smoke,
which is the same mixture re, eived by people exposed to ETS, The
mainstream smoke was vented, through a long tube in which
particulate matter settled out, to the low dose chamber, making it
similar to exhaled mainstream smoke, also a component of real
ETS .
As we noted in our report, our low dose exposure was similar to
ON found in a smoky bar -, the high dose exposure was -2 to - 10
times higher (depending on which component of ETS one consid-
ers) . Although these are relatively smoky environments, it is impor-
tant to emphasize that the exposure was brief, only 300 h over 10
weeks. This period is short, even in comparison with a rabbit's 7- to
8-year life span .
Wu points out that there are other risk factors
for atherosclerosis
besides ETS. We agree . The existence of other risk factors, how-
ever, does not mean that ETS exposure is not one of them .
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